{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:59:41Z","timestamp":1790852381405,"version":"4.1.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The gut microbiome has emerged as an important regulator of host immunity through the production of diverse bioactive metabolites. The gut microbiome has emerged as an important regulator of host immunity through the production of diverse bioactive metabolites. Microbiota-derived metabolites influence immune cell function and contribute to the maintenance of immune homeostasis, serving as key molecular mediators of host\u2013microbiota communication. Importantly, while evidence is emerging that these metabolites affect immune checkpoint signaling, less is known about the molecular mechanisms behind these interactions. Recent research demonstrated that SCFAs, secondary bile acids, indoles derived from tryptophan, inosine, polyamines and other microbial metabolites affect the immune checkpoints through epigenetics, metabolism, receptor signaling, and intracellular pathway modulation. These interactions affect the expression and functioning of key immune checkpoint molecules such as PD-1, PD-L1, CTLA-4, LAG-3, TIGIT, TIM-3 and VISTA. In this review, we summarize current knowledge regarding the Metabolite\u2013Immune Checkpoint Axis, stressing the role of metabolites derived from microbiota in the regulation of immune checkpoints. We elaborate on the molecular mechanisms of these interactions and their significance in the context of cancer, autoimmune disorders, chronic inflammatory disorders, and infectious diseases. We also provide insights regarding the developing therapeutic strategies based on microbiome-modulated therapy. Finally, we highlight key knowledge gaps and future research directions required for the clinical translation of microbiome-based personalized therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1970192","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:46:16Z","timestamp":1790851576000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic regulation of immune checkpoint signaling by microbial metabolites: mechanisms, therapeutic potential, and future perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Asiya","family":"Nazir","sequence":"first","affiliation":[{"name":"College of Health Sciences, Abu Dhabi University","place":["Abu Dhabi, United Arab Emirates"]},{"name":"Division of Drug Discovery & Development Research, Cancer Research Institute, Office of Research and Sponsored Programs, Abu Dhabi University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafia","family":"Nazir","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Skims Medical College and Hospital, Jammu and Kashmir","place":["Srinagar, Kashmir, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Sponsored Research, Division of Research Connect Lovely Professional University","place":["Phagwara Punjab, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Touseef","family":"Amna","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, Al-Baha University","place":["Al-Baha, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zienab Fawzy Reiad","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Integrative Agriculture (INAG), College of Agriculture and Veterinary Medicine (CAVM), United Arab Emirates University (UAEU)","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"469\u2013","DOI":"10.1186\/s12951-026-04376-4","article-title":"Decoding the gut microbiota-immune dialogue: from bidirectional axis to therapeutic applications","volume":"24","author":"Liu","year":"2026","journal-title":"J Nanobiotechnol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/biology15080635","article-title":"From microbial ecology to functional components in microbe\u2013host interactions","volume":"15","author":"Wang","year":"2026","journal-title":"Biology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1607388","article-title":"Gut microbiota: a promising new target in immune tolerance","volume":"16","author":"Almansour","year":"2025","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.imlet.2023.01.003","article-title":"The intestinal microenvironment shapes macrophage and dendritic cell identity and function","volume":"253","author":"Filardy","year":"2023","journal-title":"Immunol Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2490207","article-title":"Gut microbiota and epigenetic inheritance: implications for the development of IBD","volume":"17","author":"Guo","year":"2025","journal-title":"Gut Microbes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70168","article-title":"Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm"},{"key":"B7","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.premed.2025.100018","article-title":"Microbiome-guided precision medicine: Mechanistic insights, multi-omics integration, and translational horizons","volume":"3","author":"Shahid","year":"2025","journal-title":"J Precis Medicine: Health Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111817","article-title":"Immunomodulatory roles of microbiota-derived short-chain fatty acids in bacterial infections","volume":"141","author":"Ranjbar","year":"2021","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1674818","DOI":"10.3389\/fimmu.2025.1674818","article-title":"The role of immune checkpoint molecules in cancers","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduction Targeted Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1401967","article-title":"Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16244271","article-title":"Insights into the relationship between the gut microbiome and immune checkpoint inhibitors in solid tumors","volume":"16","author":"Ciernikova","year":"2024","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1675677","article-title":"Microbial metabolites and their influence on the tumor microenvironment","volume":"16","author":"Duan","year":"2025","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/gidisord7040077","article-title":"Beyond digestion: The gut microbiota as an immune\u2013metabolic interface in disease modulation","volume":"7","author":"Mohammad","year":"2025","journal-title":"Gastrointestinal Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13112516","article-title":"Gut microbiome and immune system crosstalk in chronic inflammatory diseases: a narrative review of mechanisms and therapeutic opportunities","volume":"13","author":"Feng","year":"2025","journal-title":"Microorganisms"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/17534259251392993","article-title":"Bridging two worlds: Host microbiota crosstalk in health and dysregulation","volume":"31","author":"Sanam","year":"2025","journal-title":"Innate Immun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduction Targeted Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s44351-025-00037-3","article-title":"Host-microbe interactions at barrier tissues and immunomodulation: a scoping review","volume":"2","author":"Chigozie","year":"2025","journal-title":"Discover Bacteria"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/itt.s601152","article-title":"A review of aryl hydrocarbon receptor-mediated immune regulation in cutaneous squamous cell carcinoma progression","volume":"15","author":"Han","year":"2026","journal-title":"ImmunoTargets Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-024-01026-5","article-title":"Regulation of the immune system by the resident intestinal bacteria","volume":"146","author":"Kamada","year":"2014","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00281-024-01026-5","article-title":"The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation","author":"Okumura","year":"2025","journal-title":"Semin Immunopathology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaf038","article-title":"Mechanisms conferring multi-layered protection against intestinal Salmonella Typhimurium infection","volume":"49","author":"Kroon","year":"2025","journal-title":"FEMS Microbiol Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.7150\/ijbs.79430","article-title":"The role of gut microbiota in T cell immunity and immune mediated disorders","volume":"19","author":"Shim","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"20251285","DOI":"10.1515\/biol-2025-1285","article-title":"The Th17\/Treg axis: a key to understanding and treating autoimmune disorders","volume":"21","author":"Xie","year":"2026","journal-title":"Open Life Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100384","DOI":"10.1016\/j.metop.2025.100384","article-title":"Harmonizing gut microbiota dysbiosis: unveiling the influence of diet and lifestyle interventions","volume":"27","author":"Pandit","year":"2025","journal-title":"Metab Open"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.3229","article-title":"Food, gut barrier dysfunction, and related diseases: a new target for future individualized disease prevention and management","volume":"11","author":"Liang","year":"2023","journal-title":"Food Sci Nutr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70426","article-title":"Aryl hydrocarbon receptor in health and disease","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.906258","article-title":"Microbial dysbiosis in the gut drives systemic autoimmune diseases","volume":"13","author":"Mousa","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s44466-026-00031-7","article-title":"Gut microbial metabolites and immune-related diseases","volume":"2","author":"Guo","year":"2026","journal-title":"Immun Inflammation"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.04.002","article-title":"The intestinal epithelium: central coordinator of mucosal immunity","volume":"39","author":"Allaire","year":"2018","journal-title":"Trends Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","article-title":"Interaction between the microbiota, epithelia, and immune cells in the intestine","volume":"38","author":"Kayama","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1171680","article-title":"Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity","volume":"14","author":"Guo","year":"2023","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1614879","article-title":"Short-chain fatty acids: key antiviral mediators of gut microbiota","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1511149","article-title":"Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine","volume":"12","author":"Nazir","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms21176356","article-title":"Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2026.1807302","article-title":"The immunoregulatory effect of short-chain fatty acids in type 2 diabetes mellitus","volume":"13","author":"Li","year":"2026","journal-title":"Front Nutr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fimmu.2016.00028","article-title":"GPR41 and GPR43 in obesity and inflammation\u2009-\u2009protective or causative","volume":"7","author":"Ang","year":"2016","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s540163","article-title":"The role of butyric acid and microorganisms in chronic inflammatory diseases and microbiome-based therapeutics","volume":"18","author":"Liu","year":"2025","journal-title":"J Inflammation Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1687901","DOI":"10.3389\/or.2025.1687901","article-title":"Gut microbiota-immunity cascade in hepatocellular carcinoma: mechanisms and therapeutic opportunities","volume":"19","author":"Yang","year":"2025","journal-title":"Oncol Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41522-025-00785-9","article-title":"Gut microbiota and SCFAs improve the treatment efficacy of chemotherapy and immunotherapy in NSCLC","volume":"11","author":"Yang","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/cells14080595","article-title":"Phenotyping the chemical communications of the intestinal microbiota and the host: secondary bile acids as postbiotics","volume":"14","author":"Urbani","year":"2025","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2025.1646382","article-title":"Metabolic interplay of SCFA's in the gut and oral microbiome: a link to health and disease","volume":"6","author":"Nireeksha","year":"2025","journal-title":"Front Oral Health"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1607899","article-title":"Bile acids affect intestinal barrier function through FXR and TGR5","volume":"12","author":"Song","year":"2025","journal-title":"Front Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/biof.70078","article-title":"Bile acids as key mediators of the gut microbiota-immune axis: potential biomarker and therapeutic perspectives","volume":"52","author":"Baldi","year":"2026","journal-title":"BioFactors (Oxford England)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.1c04145","article-title":"Tryptophan supplementation increases the production of microbial-derived AhR agonists in an in vitro simulator of intestinal microbial ecosystem","volume":"70","author":"Koper","year":"2022","journal-title":"J Agric Food Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1209613","article-title":"Modulation of immunity by tryptophan microbial metabolites","volume":"10","author":"Li","year":"2023","journal-title":"Front Nutr"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1668173","article-title":"The AhR\/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects","volume":"16","author":"Kang","year":"2025","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1765550","article-title":"Gut microbiota-regulated tryptophan metabolism in breast cancer: mechanisms and therapeutic perspectives","volume":"16","author":"Yan","year":"2026","journal-title":"Front Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00262-025-04111-2","article-title":"Inosine shapes PD-1 blockade responses and synergizes with dual PD-1\/CTLA-4 immunotherapy to enhance antitumor immunity","volume":"74","author":"Narikawa","year":"2025","journal-title":"Cancer immunology immunotherapy CII"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115064","article-title":"Metabolic reprogramming, sensing, and cancer therapy","volume":"43","author":"Mao","year":"2024","journal-title":"Cell Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1675065","article-title":"Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers","volume":"16","author":"Zeng","year":"2025","journal-title":"Front Microbiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40364-026-00930-2","article-title":"Decoding the microbiome-immune crosstalk in cancer: from mechanisms to therapeutic translation","volume":"14","author":"Zhao","year":"2026","journal-title":"biomark Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02227-2","article-title":"The role of gut microbial metabolites in the T cell lifecycle","volume":"26","author":"Tran","year":"2025","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1720700","article-title":"Aryl hydrocarbon receptor: a potential target for natural products in the treatment of inflammatory bowel disease","volume":"17","author":"Ran","year":"2026","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s513325","article-title":"The role of pattern recognition receptors in epigenetic and metabolic reprogramming: insights into trained immunity","volume":"18","author":"Li","year":"2025","journal-title":"J Inflammation Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1785607","article-title":"Host-gut microbiota interactions in health and disease: mechanisms and intervention strategies","volume":"17","author":"Han","year":"2026","journal-title":"Front Microbiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/cells14120920","article-title":"Roles of bile acid-activated receptors in monocytes-macrophages and dendritic cells","volume":"14","author":"Jia","year":"2025","journal-title":"Cells"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1710880","article-title":"Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy","volume":"16","author":"Luo","year":"2025","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3390\/cancers17071252","article-title":"Optimizing cancer treatment through gut microbiome modulation","volume":"17","author":"Kim","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1634814","article-title":"Inosine: biofunctions and the roles in human diseases","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/cells15110957","article-title":"Epigenetic modulators: role of gut microbiome in transformation of nutrient bioactives and host gene regulation","volume":"15","author":"Edkaidek","year":"2026","journal-title":"Cells"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3390\/ijms27083354","article-title":"Epigenetic alterations in microbiome-host interactions in inflammatory and autoimmune diseases","volume":"27","author":"Basher","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-025-03509-1","article-title":"Epigenetic regulation in gynecological cancers: a paradigm shift in immunotherapy strategies","volume":"44","author":"Zhao","year":"2025","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1718358","article-title":"The interaction between gut microbiota and host DNA methylation in the pathogenesis and therapy of inflammatory bowel disease","volume":"16","author":"Jin","year":"2025","journal-title":"Front Microbiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1690552","article-title":"Beyond the genome: epigenetic regulation of immune responses and T cells in brain tumors","volume":"16","author":"Sun","year":"2025","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41392-024-02030-9","article-title":"Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121138","article-title":"The impact of microbiota on PD-1\/PD-L1 inhibitor therapy outcomes: A focus on solid tumors","volume":"310","author":"Najafi","year":"2022","journal-title":"Life Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1862118","article-title":"Modulation of the PD-1\/PD-L1 axis and tumor immunity by metals and metalloids: mechanistic insights and human health implications","volume":"17","author":"Lu","year":"2026","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100773","article-title":"Microbiota-derived metabolites: Key modulators of cancer immunotherapies","volume":"6","author":"Perl","year":"2025","journal-title":"Med (New York NY)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1043970","article-title":"Inosine: A bioactive metabolite with multimodal actions in human diseases","volume":"13","author":"Kim","year":"2022","journal-title":"Front Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-026-11024-8","article-title":"Microbiome-modulating strategies in anticancer therapy: A review of current evidence and recommendations for further treatment improvement","author":"B\u00f6hm","year":"2026","journal-title":"Probiotics Antimicrob Proteins"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04186-5","article-title":"Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial","volume":"32","author":"Duttagupta","year":"2026","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1038\/s41467-026-72178-1","article-title":"Microbiota-derived metabolites as modulators of cancer immunotherapy response","volume":"17","author":"Toner-Bartelds","year":"2026","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-026-02631-6","article-title":"Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications","volume":"11","author":"Liu","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1091124","article-title":"Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery","volume":"13","author":"Du","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1970192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:46:17Z","timestamp":1790851577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1970192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2026.1970192"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1970192","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1970192"}}